CompletedPhase 2NCT02807142

Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia

Studying Syringomyelia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Puerta de Hierro University Hospital
Principal Investigator
Jesús Vaquero Crespo, M.D., M.D
Hospital Universitario Puerta de Hierro-Majadahonda
Intervention
NC 1 cell therapy(biological)
Enrollment
6 target
Eligibility
18-70 years · All sexes
Timeline
2016 – 2018

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02807142 on ClinicalTrials.gov

Other trials for Syringomyelia

Additional recruiting or active studies for the same condition.

See all trials for Syringomyelia →

← Back to all trials